A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study

The Journal of Clinical Investigation
A Tybjaerg-HansenB G Nordestgaard

Abstract

A common mutation (G-455--> A) in the promoter region of the beta-fibrinogen gene has been associated with elevated plasma fibrinogen levels. Whether fibrinogen genotype affects plasma fibrinogen levels and risk of ischemic heart disease in the general population has not been studied. We investigated the association between fibrinogen genotype, plasma fibrinogen levels, and ischemic heart disease in a general population sample (n = 9,127). The A-allele (relative frequency, 0.20) was associated with elevated plasma fibrinogen levels in both genders (P < 0.001). While the effect of the A-allele on fibrinogen level was additive in men, the effect was dominant in postmenopausal women. The A-allele raising effect appeared to be two- to threefold greater in individuals with ischemic heart disease than in those without. An increase of 1 SD in plasma fibrinogen increased the odds ratio for ischemic heart disease by approximately 20% (P < 0.01 for women and < 0.005 for men). However, the frequency of the A-allele was similar in those with and without ischemic heart disease, and genotype was not a predictor of disease. These results demonstrate that the (G-455--> A) mutation in the promoter region of the beta-fibrinogen gene is associate...Continue Reading

References

Sep 4, 1987·JAMA : the Journal of the American Medical Association·W B KannelR B D'Agostino
Aug 23, 1984·The New England Journal of Medicine·L WilhelmsenG Tibblin
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J HeinrichJ van de Loo
Jun 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·P Y ScarabinF Cambien

❮ Previous
Next ❯

Citations

Apr 5, 2001·Current Atherosclerosis Reports·D Lillicrap
Mar 15, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Georg Endler, Christine Mannhalter
Feb 13, 2001·Atherosclerosis·R Frikke-SchmidtB G Nordestgaard
Aug 2, 2002·Obstetrics and Gynecology·Jaana LaasanenSeppo Heinonen
Oct 29, 2000·British Journal of Haematology·C J DoggenF R Rosendaal
Dec 12, 2001·British Journal of Haematology·R F Franco, P H Reitsma
May 29, 1998·The New England Journal of Medicine·A Tybjaerg-HansenB G Nordestgaard
Sep 23, 2003·QJM : Monthly Journal of the Association of Physicians·S Kamath, G Y H Lip
Feb 21, 2004·QJM : Monthly Journal of the Association of Physicians·G Davey SmithS Ebrahim
Jul 17, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Maren T Scheuner
Aug 12, 2005·Current Opinion in Hematology·Moniek P M de Maat, Maartje Verschuur
Feb 24, 2001·Molecular Pathology : MP·T C SykesD Mosquera
Dec 12, 2012·American Journal of Respiratory and Critical Care Medicine·Jolanta KlovaiteMarianne Benn
Feb 20, 2010·BMC Medical Genetics·Eirini V TheodorakiGeorge V Dedoussis
Jun 17, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Despoina M ChoumerianouGeorge V Z Dedoussis
May 8, 2013·Neurologia i neurochirurgia polska·Aleksandra GoleniaAgnieszka Slowik
May 5, 2009·Thrombosis Research·Loukianos S RallidisDimitrios T Kremastinos
Dec 24, 2005·Journal of Thrombosis and Haemostasis : JTH·E M BladbjergJ Hjelmborg
Mar 12, 2008·Journal of Thrombosis and Haemostasis : JTH·K JoodC Jern
Jun 17, 2000·Baillière's Best Practice & Research. Clinical Haematology·P J Grant, S E Humphries
Feb 4, 2005·Metabolism: Clinical and Experimental·Finn Edler Von EybenRiel Von Eyben
Jun 21, 2006·The American Journal of Cardiology·Kenneth Jay MukamalGorm Jensen
Apr 1, 2006·Critical Reviews in Clinical Laboratory Sciences·Massimo FranchiniGiuseppe Lippi
Jun 16, 2015·Seminars in Vascular Surgery·Reagan L Ross, Adam W Beck
Nov 1, 2005·Journal of the American College of Cardiology·Geoffrey S GinsburgL Kristin Newby
Apr 12, 2003·International Journal of Epidemiology·George Davey Smith, Shah Ebrahim
Nov 3, 2016·Journal of Lipid Research·Børge G Nordestgaard, Anne Langsted
Nov 25, 2003·Journal of Thrombosis and Haemostasis : JTH·A DilleyJ Eldridge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.